Company / Revenue
PLUS THERAPEUTICS, INC. Revenue History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$5.8M
FY2025
5-year range
$2.7M / $5.8M
FY2021-FY2025
Trend
+18.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $3M in FY2018 to $9M in FY2014.
Based on SEC 10-K filings.
$6M in FY2025 with a 10-year CAGR of -2.0%.
Improved from $3M to $6M over the past 7 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -2.0%
Key checks
Key Insights
- In FY2025, revenue increased 18.5% year-over-year.
- Peak revenue was recorded in FY2014.
- Lowest revenue in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.8M | +18.5% |
| FY2024 | $4.9M | +82.7% |
| FY2018 | $2.7M | -42.2% |
| FY2017 | $4.7M | -3.8% |
| FY2016 | $4.8M | -32.1% |
| FY2015 | $7.1M | -18.2% |
| FY2014 | $8.7M | +9.1% |
| FY2013 | $8.0M | -3.3% |
| FY2012 | $8.3M | +41.4% |
| FY2011 | $5.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026